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RING-E3ted the cellular mechanism underlying the degradation of heme oxygenase-1
(HO-1), an endoplasmic reticulum (ER)-anchored protein. The turnover of HO-1 induced in vascular smooth
muscle cells (VSMCs) was signiﬁcantly attenuated by proteasome inhibitors, suggesting the involvement of a
proteasome-mediated pathway. High molecular weight ubiquitin conjugates were co-immunoprecipitated
with HO-1 from VSMCs after proteasome inhibition, and HO-1 ubiquitination was conﬁrmed in HEK293 cells
overexpressing His-tagged HO-1 and HA-tagged ubiquitin. Endogenous p97, an ATPase, and Ufd1, both
implicated as essential components in the ER-associated degradation pathway (ERAD), were co-eluted with
His-tagged HO-1 from metal afﬁnity resin. Knockdown of either p97 or Ufd1 in HEK293 cells using speciﬁc
siRNA signiﬁcantly prolonged the half-life of endogenously induced HO-1 and slowed the degradation of
ubiquitinated HO-1. HO-1 ubiquitination in HEK293 cells was enhanced by zinc chloride, but suppressed with
a zinc chelator (N,N,N′,N′-tetrakis(2-pyridylmethyl)ethyl-enediamine), suggesting the involvement of a
RING-E3 ligase in this process. Collectively, these data indicate that HO-1 protein turnover is regulated by the
ubiquitin–proteasome system through the ERAD pathway.
© 2008 Elsevier B.V. All rights reserved.1. Introduction
Heme oxygenase (HO) is the rate-limiting catalytic enzyme in the
oxidative degradation of cellular heme, producing biliverdin, carbon
monoxide (CO), and free iron as reaction byproducts [1,2]. HO-1 and
HO-2 are the inducible and constitutive forms of HO, respectively [3].
Although the existence of HO-3 was previously reported, a recent
study showed that it is a processed pseudogene derived from HO-2
gene [4]. HO-1 expression is highly upregulated by a variety of
oxidative stress-inducing agents, including ultraviolet irradiation,
heavy metal exposure, inﬂammatory agents, and its own substrate,
heme. Most cell types and tissues express only low levels of HO-1
under normal physiological conditions. One exception is the spleen,
which is constantly exposed to high concentrations of heme released
from the hemoglobin of aged erythrocytes. Over the last decade,
overwhelming evidencehas accumulated indicating that the induction
of HO-1 represents an important cytoprotective defense mechanism
against oxidative insults by virtue of the actions of its reaction
byproducts, biliverdin and CO [5,6]. Biliverdin and its metabolite
bilirubin are potent antioxidants, while CO is an important signaling
molecule with vasodilatory, anti-inﬂammatory, anti-proliferative, and
anti-apoptotic activities in different cell types. Increasing evidencees, Academia Sinica, Taipei 115,
l rights reserved.supporting the functional importance of HO-1 in a variety of patholo-
gical conditions associated with cellular stress has stimulated con-
siderable interest in themechanisms underlying HO-1 gene induction,
particularly at the transcriptional level [7–13]. However, the mechan-
ism of HO-1 protein turnover following induced expression has not
been reported.
HO-1 is anchored to the endoplasmic reticulum (ER) through a
single transmembrane domain located at the carboxyl-terminus
[14]. In recent years, studies in yeast and mammalian cells have
revealed that many ER-associated aberrant and normal proteins are
degraded by the ubiquitin–proteasome system through an ER-
associated degradation (ERAD) pathway [15,16]. Although ERAD was
initially thought to function primarily as a quality-control system
eliminating misfolded or damaged proteins in the ER, it is now
recognized that ERAD also mediates the regulated degradation of
speciﬁc ER-associated native proteins. ERAD protein substrates ﬁrst
undergo ubiquitination in the ER membrane through the coordinated
action of three enzymes, ubiquitin-activating enzyme E1, ubiquitin-
conjugating E2 and ubiquitin ligase E3. E3 ligases provide the substrate
speciﬁcity required for protein ubiquitination. To date, three different
classes of E3 ligases have been identiﬁed [17]. The HECT ligases, which
contain a domain homologous to E6AP C-terminus, form thiol–ester
intermediates with ubiquitin, and then transfer it to the protein sub-
strate. In contrast, the U-box-containing E3 ligases and zinc-binding
RING-E3 ligases canmediate the direct transfer of ubiquitin from E2 to
substrates.
1827P.-H. Lin et al. / Biochimica et Biophysica Acta 1783 (2008) 1826–1834The dislocation of ubiquitinated ER-associated proteins from the ER
to the cytoplasm for destruction by the 26S proteasome requires a
cytoplasmic ATPase complex, consisting of p97, an AAA-type ATPase,
and its cofactors, Ufd1 and Npl4 [18–20]. Ufd1 and NP14 form a
heterodimer, and then assist the recruitment and interaction of p97
with ubiquitinated protein substrates on the ER membrane. p97 has
also been shown to physically interact with the E3 ligase, effectively
coupling the ubiquitination and translocation of targeted substrates
during ERAD [21–26]. In order to understand the mechanism under-Fig.1.HO-1 turnover in VSMCs is not affected by brefeldin A or inhibitors of lysosomal protea
without 20 μMCHX for indicated times. Levels of HO-1 and β-actin (internal control) protein
was quantiﬁed by densitometry. Data are mean±SD. ⁎Pb0.01 vs HO-1 level at time zero. (B)
turnover of HO-1 was then determined by CHX pulse-chase experiment, followed byWestern
(C) VSMCs infected with or without Adv-HO-1 (5 MOI) for 24 h followed by treatment with o
Levels of HO-1 were then examined byWestern blot analysis and quantiﬁed by densitometry
with or without Adv-HO-1 were treated with or without CHX and/or chloroquine (100 μM), l
then quantiﬁed. Data are mean±SD. ⁎Pb0.01 vs cells treated with Adv-HO-1 alone.lying the regulation of steady-state HO-1 turnover, the present study
explores the role of the ubiquitin–proteasome system in the degrada-
tion of HO-1 and the potential involvement of ERAD in this process.
2. Materials and methods
2.1. Materials
Brefeldin A, chloroquine diphosphate, cycloheximide (CHX), leupeptin, MG132,
and N,N,N′,N′-tetrakis(2-pyridylmethyl)ethyl-enediamine (TPEN) were purchased fromses. (A) VSMCs with or without Adv-HO-1 (5MOI) infection for 24 hwere treated with or
were examined byWestern blot analysis. The effect of CHX chase on HO-1 protein levels
Endogenous HO-1 was induced by treatment of VSMCs with 2 μM CoPPIX for 24 h. The
blot analysis and densitometry. Data are mean±SD. ⁎Pb0.01 vs HO-1 level at time zero.
r without CHX (20 μM) in combinationwith or without brefeldin A (BFA, 20 μM) for 12 h.
. Data are mean±SD. ⁎Pb0.01 vs cells treated with Adv-HO-1 alone. (D) VSMCs infected
eupeptin (350 μM) or NH4Cl (20 mM) as indicated for 12 h. HO-1 protein remaining was
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from Calbiochem (San Diego, California). Cobalt protoporphyrin IX (CoPPIX) was
obtained from Frontier Scientiﬁc (Logan, Utah). 3-(4, 5-dimethylthiazol-2-yl)-5-(3-
carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium salt (MTS) was purchased
from Promega (Madison, Wisconsin). Fetal calf serum (FCS), Dulbecco's Modiﬁed Eagle
medium (DMEM), Opti-MEM, and Lipofectamine 2000 were from Invitrogen (Carlsbad,
California). Control scrambled siRNA (sc-37007), p97 siRNA (sc-37187), Ufd1 siRNA
(sc-41689), a rabbit polyclonal ubiquitin antibody (sc-9133), a goat polyclonal Ufd1
antibody (sc-9296), and a rabbit polyclonal p27 antibody (sc-527) were purchased from
Santa Cruz Biotechnology (Santa Cruz, California). The sense sequences of siRNAs against
p97 were GAAGAUUCGGAUGAAUAGATT, CAUGCCCUGAUGUGAAGUATT, and CCAAGG-
GAGUUCUGUUCUATT; and against Ufd1 were CCUAUCCCAUGCUGUUCAATT, GGAU-
GAUGCAGAACUUACUTT, and GCAUCCCUAAUUCUGUCAATT. A mouse monoclonal p97
antibody (ab19444) was purchased from Abcam (Cambridge, Massachusetts). A mouse
monoclonal HA-tag antibody (2367) was purchased from Cell Signaling (Danvers,
Massachusetts). The Effectene transfection reagent was purchased fromQiagen (Hilden,
Germany). TALON™metal afﬁnity resinwas purchased from BD Biosciences (San Diego,
California). TrueBlot™ anti-rabbit Ig IP beads were purchased from eBioscience
(San Diego, California).
2.2. Recombinant adenovirus and plasmid constructs
A recombinant adenovirus containing the human HO-1 gene (Adv-HO-1) was
prepared as described previously [27]. For the construction of the plasmid containing a
His-tagged-HO-1 gene, a human HO-1 cDNA fragment containing the entire HO-1
coding region was ampliﬁed by PCR using sense and anti-sense primers containing
EcoRI and NotI restriction sites, respectively, and then subcloned into the EcoRI/NotI
site of digested pcDNA3.1/His©C vector. The primers used were: 5′-AATGAATTCATG-
GAGCGTCCGCAACC-3′ and 5′-AAGCGGCCGCATTCACATGGCATAAA-3′. The HA-tagged
ubiquitin plasmid (PMT123) was generously provided by Dr. Dirk Bohmann (University
of Rochester).Fig. 2. HO-1 degradation is blocked by proteasome inhibitors. (A) VSMCs infected with or with
indicated for 12h. Levels ofHO-1were then determined byWesternblot analysis andquantiﬁed
vs cells treatedwithAdv-HO-1 andCHX. (B) VSMCswere treatedwith CoPPIX (2 μM) for 24 h, foll
quantiﬁedbyWesternblot analysis anddensitometry. Data aremean±SD.⁎Pb0.01 vs cells treate
with 5MOI of empty Advor Adv-HO-1 for 24 h, followed by treatmentwith the indicated concen2.3. Preparation of polyclonal anti-HO-1 antibody
A human HO-1 cDNA fragment encoding amino acids 13–260 was ampliﬁed by PCR
and subcloned into the NcoI/BglII sites of digested pQE-60 vector (Qiagen) using the
primers: 5′-ATGCCCATGGATTTGTCAGAGG-3′ and 5′-AGCCTGAGATCTGGTGTTGAGT-3′.
Recombinant protein containing 6× His-tag at the N-terminus was induced in
transformed Escherichia coli (strain JM109), puriﬁed by TALON™ metal afﬁnity resin,
and then used as an antigen for anti-HO-1 antibody production in a rabbit. The
speciﬁcity of the antibody was conﬁrmed by Western blot analysis using recombinant
protein as well as whole cell lysates prepared from Adv-HO-1-infected cells.
2.4. Cell culture
Rat aortic smooth muscle cells (VSMCs) were isolated as described previously and used
for experiments at passages 10–17 [28]. HEK293 cells were originally obtained from ATCC
(Manassas, Virginia) and cultured in DMEM containing 10% FCS and antibiotics. Unless
speciﬁed, cellswere reseededat24hprior tovarious treatments. Foradenovirus experiments,
VSMCs subcultured at a density of 2×105/dish in 3.5-cmdisheswere incubated for 2 hwith 5
MOI of either empty adenovirus (Adv) or recombinant Adv-HO-1 in serum-freemedium. An
equal volume of complete medium containing 10% FCS was then added into culture and
incubation continued for another 18h. Culturemediumwas then changed toDMEMmedium
containing 1% serum and cells were treated with various agents as indicated. For transient
transfection experiments, HEK293 cells subcultured at a density of 6×105/dish in 10-cm
dishes were transfected separately with HA-tagged ubiquitin cDNA, His-tagged HO-1 cDNA,
or both cDNAs using the Effectene transfection reagent according to the manufacturer's
instructions. After 24 h, cells were subjected to various treatments as indicated.
2.5. SiRNA knockdown experiments
HEK293 cells seeded at a density of 2×105/dish in 6-cm dishes were cultured with
DMEM containing 10% FCS without antibiotics. After 24 h, culturemediumwas replacedout Adv-HO-1 for 24 h were treated with or without CHX (20 μM) and MG132 (1 μM) as
by densitometry. Data aremean±SD. ⁎Pb0.01 vs cells treatedwithAdv-HO-1 alone. †Pb0.01
owedby incubationwith orwithoutCHXandMG132as indicated. HO-1 protein levelswere
dwithCoPPIX alone; †Pb0.01 vs cells treatedwithCoPPIX andCHX. (C)VSMCswere infected
trations of lactacystin for 12 h.HO-1 protein levelswere examined byWestern blot analysis.
Fig. 3. Ubiquitination of HO-1. (A) VSMCswere infectedwith 5MOI of Advor Adv-HO-1 for
24 h, followedby treatmentwith orwithout 10 μMofMG132or lactacystin as indicated for
12 h. Cell lysates were prepared and subjected to immunoprecipitation with an HO-1-
speciﬁc antibody as described in Materials and methods. The immunoprecipitates were
then electrophoresed and immunoblottedwith antibodies against HO-1 or ubiquitin (Ub).
Non-speciﬁc bands are marked with ⁎. (B) HEK293 cells were transfected with His-tagged
HO-1 plasmid (His-HO-1; 0.5 μg), HA-tagged-ubiquitin plasmid (HA-Ub; 2 μg), or both
plasmids for 24 h. Cells were harvested and cell lysates were prepared. His-tagged HO-1
proteinwas puriﬁed withmetal afﬁnity resin and immunoblotted with antibodies against
HO-1 or HA-tag as described in Materials and methods. ⁎ indicates non-speciﬁc bands.
(C) HEK293 cells were transfected with both His-tagged HO-1 and HA-tagged-ubiquitin
plasmids for 24 h, followed by treatment with or without MG132 (10 μM) for 12 h. Cells
were then harvested, homogenized, and fractionated to isolate the cytosolic fraction and
microsomal membranes. His-tagged HO-1 protein was then puriﬁed from cytosol and
solubilized microsomal fractions by metal afﬁnity resin, and immunoblotted with anti-
bodies against HO-1 and HA-tag.
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siRNA, p97 siRNA or Ufd-1 siRNA mixed with 6 μl of Lipofectamine 2000 in Opti-MEM.
After 6 h, transfection medium was removed and replaced with DMEM containing 10%
FCS. After 24 h, cells were replated in 10-cm dishes and allowed to grow for an
additional 24 h, followed by treatment with 20 μM CoPPIX for 24 h or 10 μMMG132 for
12 h. Cells in each 10-cm dish were then split into four 3.5-cm dishes and treated with
20 μM CHX for various times as indicated.
2.6. Protein degradation assay
Protein stability was determined by CHX chase experiment. Brieﬂy, 20 μM of CHX
was added into medium of cultured cells for the indicated times. Cells were then
harvested, lysed with 50 mM Tris–HCl, pH 7.4, containing 1% Triton X-100, 0.1% SDS
and a protease inhibitor cocktail, and centrifuged at 13,200 g for 15 min at 4 °C. The
supernatant was then removed and protein concentrations determined using a Bio-Rad
protein assay. Protein levels were then evaluated by Western blot analysis.
2.7. Western blot analysis
Cell lysates (20 μg) were electrophoresed on 10% SDS-polyacrylamide gels and
blotted onto Immobilon-P membranes (Millipore). Protein blots were blocked with 5%
skim milk in PBS containing 0.1% Tween-20 (PBST) for 1 h at room temperature,
followed by incubation with primary antibodies (HO-1, 1:2000; ubiquitin, 1:1000; HA,
1:2000; p97, 1:1000; Ufd1, 1:1000, p27, 1:500; or β-actin, 1:4000) for 1 h in PBST
containing 1% skim milk. After 3 washes, blots were incubated with horseradish
peroxidase-conjugated secondary antibodies for an additional 1 h. Antigen-antibody
complexes were detected by using chemiluminescence.
2.8. HO-1 immunoprecipitation
VSMCs infected with Adv or Adv-HO-1 as described above were incubated with
10 μM of MG132 or lactacystin in culture for 12 h. Cells were then lysed in 50 mM Tris–
HCl, pH 7.4, containing 150 mM NaCl, 1 mM EDTA, 1% NP-40, 0.025% sodium
deoxycholate, 1 mM NaF, 1 mM dithiothreitol (DTT) and a protease inhibitor cocktail.
Cell lysates (500 μg) were incubated with 40 μl of TrueBlot™ anti-rabbit Ig IP beads at
4 °C for 1 h with shaking. After centrifugation, supernatants were incubated with 2 μl of
anti-HO-1 antiserum at 4 °C overnight. Forty μl of anti-rabbit Ig IP beads were then
added to supernatants and incubated for an additional 1 h. Beads were collected by
centrifugation and washed twice with lysis buffer, and then the bound proteins were
eluted with 50 μl of 1× SDS sample buffer and subjected to Western blot analysis.
2.9. His-tagged HO-1 protein isolation
HEK293 cells transfected with His-tagged HO-1 plasmid DNA were lysed with
50 mM Tris–HCl, pH 7.5, containing 300 mM NaCl, 1% NP-40, 0.1% SDS, 1 mMNaF, 1 mM
DTT,1mMPMSF, 50 μMMG132,10mMNa3VO4, 5mMN-ethylmaleimide and a protease
inhibitor cocktail. After centrifugation at 13,200 g for 15 min at 4 °C, supernatant was
removed and immediately used in the isolation of His-tagged HO-1 protein by metal
afﬁnity resin. Brieﬂy, 500 μg of cell lysate was incubated with 10 μl of TALON™ metal
afﬁnity resin at room temperature for 30 min with rotation. The resin was collected by
centrifugation and washed 3 times with lysis buffer, then the bound proteins were
eluted by 50 μl of 1× SDS sample buffer and subjected to Western blot analysis.
2.10. Subcellular fractionation
HEK293 cells transfected with HA-tagged ubiquitin and His-tagged HO-1 plasmids
were incubated with or without 10 μMMG132 for 12 h. Cells were harvested in 50 mM
Tris–HCl, pH 8.0, containing 1 mM 2-mercaptoethanol, 0.32 M sucrose, 0.1 mM PMSF,
and a protease inhibitor cocktail and then homogenized by passing through a 27-gauge
syringe 20 times. Cell lysates were centrifuged at 1100 g at 4 °C for 15 min. Supernatants
were subjected to further centrifugation at 227,000 g for 1 h at 4 °C in order to separate
the cell cytosol from microsomes. Microsomal proteins were then solubilized with
buffer containing 50 mM Tris–HCl, pH 7.5, 300 mMNaCl, 1% NP-40, 0.1% SDS, 1 mMNaF,
1 mM DTT, 1 mM PMSF, 50 μM MG132, 10 mM Na3VO4, 5 mM N-ethylmaleimide and a
protease inhibitor cocktail prior to further experiments.
2.11. Zinc effect
The effect of TPEN or ZnCl2 on the viability of HEK293 cells was assessed by
incubating cells with the indicated concentrations of TPEN or ZnCl2 for 8 h, followed by
a MTS-based colorimetric cell viability assay. To examine the effects of TPEN and ZnCl2
on protein ubiquitination, cells transfected with His-tagged HO-1 and HA-tagged
ubiquitin plasmids for 24 h were treated with the indicated concentrations of TPEN or
ZnCl2 under identical conditions, then His-tagged proteins were isolated and detected
by Western blot analysis as described above.
2.12. Statistical analysis
Data are expressed as the mean±SD of at least three independent experiments.
Group data were analyzed by one-way ANOVA. A value of Pb0.05 was considered
statistically signiﬁcant.3. Results
3.1. HO-1 degradation in VSMCs is not blocked by an inhibitor of protein
transport to the Golgi or by lysosomal inhibitors
In VSMCs, HO-1 protein transduced exogenously by infection with
recombinant Adv-HO-1 or induced endogenously by treatment with
HO-1 inducer, CoPPIX, had a half-life of around 8 h as assessed in the
presence of 20 μMof the protein synthesis inhibitor, CHX (Fig.1A and B).
Fig. 4. Involvements of p97 and Ufd1 in HO-1 turnover. (A) HEK293 cells were transfected with HA-tagged ubiquitin cDNA (2 μg) alone or in combinationwith His-tagged HO-1 cDNA
(0.5 μg) for 24 h. Cell lysates were prepared and His-tagged HO-1 proteinwas isolated by metal afﬁnity resin. Eluted proteins were electrophoresed and immunoblotted with speciﬁc
antibodies against HO-1, p97 and Ufd1. (B) and (D) HEK293 cells were transfected without (cont) or with control siRNA (con siRNA), p97 siRNA, or Ufd1 siRNA as described in
Materials and methods. Endogenous p97 and Ufd-1 protein levels were examined 72 h after transfection byWestern blot analysis. (C) and (E) HEK 293 cells were transfected without
(cont) or with the indicated siRNA for 48 h, then cells were treated with CoPPIX (20 μM) for another 24 h followed by incubation with CHX (20 μM) for indicated times. HO-1 protein
remaining after CHX chase was examined by Western blot analysis and quantiﬁed by densitometry. ⁎Pb0.01 vs control or control siRNA-treated cells.
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with brefeldin A (20 μM), a blocker of protein translocation from the ER
to the Golgi, or by inhibitors of lysosomal proteolysis, including
chloroquine (100 μM), leupeptin (350 μM) and NH4Cl (20 mM) (Fig. 1C
and D). These results indicate that HO-1 protein degradation is initiated
in the ER compartment and does not involve lysosomal degradation.
3.2. HO-1 degradation is inhibited by proteasome inhibitors
To assess whether the proteasome was required for HO-1 protein
degradation, the effect of the proteasome inhibitor MG132 on HO-1
degradation was assessed. As shown in Fig. 2A, the degradation of
exogenousHO-1protein expressed inVSMCs followingCHXpulse-chase
for 12 h was signiﬁcantly attenuated by co-treatmentwith 1 μMMG132
(35.5±4.5% vs 86.0±14.7% (MG132) of HO-1 remaining, Pb0.01).MG132
had a similar effect on endogenous HO-1 induced by CoPPIX (Fig. 2B). In
the absence of CHX, incubation of Adv-HO-1-infected cells with
lactacystin, another proteasome inhibitor, at concentrations that did
not induce endogenousHO-1 expression (2 and5 μM) resulted in greater
accumulation of exogenousHO-1 detected as compared to the untreated
control (Fig. 2C). These results suggest that the proteasome is required
for HO-1 degradation in VSMCs.Fig. 5. Effect of p97 and Ufd1 knockdown on p27 turnover. HEK293 cells were transfected with
treated with MG132 (10 μM) for 12 h to induce p27 expression. Subsequently, medium w
remaining after MG132 withdrawal in control cells (cont), or cells treated with control siRNA
Western blot analysis and quantiﬁed by densitometry.3.3. HO-1 undergoes ubiquitination
Western blot analysis of HO-1 immunoprecipitated from Adv-HO-1-
infected VSMCs using an ubiquitin-speciﬁc antibody showed a staining
pattern typical of high molecular weight ubiquitin conjugates (Fig. 3A).
To further conﬁrm that HO-1 undergoes ubiquitination, HEK293 cells
were transfected with His-tagged-HO-1 and HA-tagged-ubiquitin
plasmids, then His-tagged-HO-1 protein was isolated by metal afﬁnity
resin prior to Western blot analysis using an HA-tag speciﬁc antibody.
High molecular weight ubiquitin conjugates were detected in the
afﬁnity-puriﬁed His-tagged HO-1 preparation, even in the absence of
proteasome inhibition (Fig. 3B). Immunoblotting with an HO-1-speciﬁc
antibody detected mostly unmodiﬁed HO-1 (32 kD), whereas a high
molecular weight protein species of approximately 47 kD was also
evident in the same blot. In order to determine whether HO-1
ubiquitination occurs in ER, whole cell homogenates of HEK293 cells
cotransfected with His-tagged HO-1 and HA-tagged ubiquitin plasmids
were subjected to subcellular fractionation prior to isolation of His-
tagged HO-1 by metal afﬁnity resin. As shown in Fig. 3C, the majority of
ubiquitinatedHis-taggedHO-1was detected in themicrosomal fraction.
Proteasome inhibition with MG132 resulted in an accumulation of
ubiquitinated HO-1 detected in both the cytosol and microsomes.indicated siRNA as described in the legend of Fig. 5. At 48 h after transfection, cells were
as removed and replenished with fresh growth medium without MG132. p27 protein
(con siRNA), p97 siRNA (A) or Ufd1 siRNA (B) were examined at the indicated times by
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Since the 26S proteasome is mainly localized to the cytoplasm, we
next explored the possibility that HO-1 degradation requires the
involvement of the p97–Ufd1–Npl4 complex. Western blot analysis
showed that both endogenous p97 and Ufd1 were co-eluted from the
metal afﬁnity resin along with His-tagged HO-1 in cells cotransfected
with His-tagged-HO-1 and HA-tagged ubiquitin plasmids (Fig. 4A).
These results suggest that p97 and Ufd1 physically interact with HO-1.
In order to conﬁrm that p97 and Ufd1 are important for HO-1 protein
degradation, the half-life of endogenous HO-1 induced by CoPPIX was
determined in HEK293 cells following p97 and Ufd1 knockdown using
gene-speciﬁc siRNA. Endogenous p97 protein was substantially
reduced in cells transfected with p97-speciﬁc siRNA but not by
control siRNA (Fig. 4B). CHX chase-pulse experiments showed that the
normal half-life of endogenous HO-1 induced in HEK293 cells was
~6 h. This protein half-life was signiﬁcantly prolonged in cells
transfected with p97 siRNA (Fig. 4C). A similar effect on induced
HO-1 protein half-life was observed in cells transfected with Ufd1-
speciﬁc siRNA (Fig. 4D and E). In order to ensure that the effects of p97
and Ufd1 knockdown on HO-1 turnover were not the result of
inhibition of the ubiquitin–proteasome system, we also examined the
turnover rate of p27 protein induced in MG132-treated HEK293 cells.
As shown in Fig. 5, p27 degradation following MG132 withdrawal was
not affected by siRNA knockdown of p97 or Ufd1. These observations
support that p97 or Ufd1 knockdown speciﬁcally affects HO-1 protein
turnover without perturbing the general protein degradation by the
ubiquitin–proteasome system. In order to further conﬁrm the role of
p97–Ufd1–Npl4 complex implicated in HO-1 turnover, we next
assessed whether blockade of p97–Ufd1–Npl4 complex results in
the retarded degradation of ubiquitinated HO-1. As demonstrated in
Fig. 6, signiﬁcantly greater amounts of ubiquitinated HO-1 were
present in HEK293 cells transfected with Ufd1-speciﬁc siRNA than in
control cells. These data suggest that the p97–Ufd1–Npl4 protein
complex is required for HO-1 degradation.Fig. 6. Effect of Ufd1 knockdown on ubiquitinated HO-1. HEK293 cells were transfected
without (control) or with control siRNA (con siRNA) or Ufd1 siRNA as described in
Materials and methods. After 24 h, cells were subjected to a second transfection with
His-tagged HO-1 (0.5 μg) and HA-tagged ubiquitin (2 μg) plasmids for an additional
24 h. Cells were then lysed and His-tagged HO-1 was puriﬁed by metal afﬁnity resin
followed by immunoblotting with antibodies against HO-1 and HA-tag. The amount of
ubiquitinated HO-1 in control cells was set at 100%. Data are mean±SD. ⁎Pb0.01 vs
control.3.5. Effect of zinc on HO-1 ubiquitination
Incubation of HEK293 cells with TPEN, a Zn2+ chelator, at
concentrations up to 6 μM for 8 h did not signiﬁcantly affect cell
viability (Fig. 7A), but caused a signiﬁcant (40%, Pb0.01) reduction in
HO-1 ubiquitination (Fig. 7B). Conversely, ZnCl2 treatment increased
HO-1 ubiquitination in a dose-dependent manner, with signiﬁcant
increase observed at concentrations of 10 μM and 15 μM (Fig. 7C). The
reduction in HO-1 ubiquitination following treatment with TPEN
(6 μM) was reversed by co-treatment with ZnCl2 (10 μM) (Fig. 7D).
These results suggest the involvement of a putative RING-E3 ligase,
the activity of which is dependent upon Zn2+, in mediating the
ubiquitination of HO-1.
4. Discussion
In the present study, we demonstrated that proteasome inhibition
signiﬁcantly attenuated the degradation of both endogenous and
exogenous HO-1 and increased the accumulation of exogenous HO-1,
suggesting the involvement of the ubiquitin–proteasome system in
HO-1 turnover. This possibility was further supported by a series of
experiments showing HO-1 ubiquitination. An ubiquitin-speciﬁc
antibody detected high molecular weight ubiquitinated protein
species in HO-1 immunoprecipitates isolated from VSMCs treated
with proteasome inhibitors. HO-1 ubiquitinationwas also observed in
HEK293 cells overexpressing both His-tagged-HO-1 and HA-tagged-
ubiquitin, even in the absence of proteasomal inhibition. Immuno-
blotting of the afﬁnity-puriﬁed His-tagged HO-1 protein with an HA-
tag antibody revealed a smeared signal covering a wide range of high
molecular weight protein species. Whereas, the use of an HO-1-
speciﬁc antibody barely detected the high molecular weight species
except a speciﬁc protein band of approximately 47 kD, indicating that
the relative amounts of high molecular weight polyubiquitinated HO-
1 species are substantially lower than those of unmodiﬁed HO-1 and
the 47 kD species in resting cells.
Subcellular fractionation experiments revealed that the ubiquiti-
nated HO-1 was predominantly associated with microsomal fraction
of the cells, suggesting that putative HO-1 degradation by the
cytoplasmic 26S proteasome required translocation of HO-1 as an
ERAD substrate. There is considerable evidence suggesting that the
p97–Ufd1–Npl4 complex is a key component in the transport of
ubiquitinated ERAD substrates in mammalian cells [18–20]. The
ATPase p97 itself can interact with unmodiﬁed ERAD substrates as
they emerge from the ER, and can synergize with Ufd1 in the
recognition of ubiquitinated substrates [20]. The binding of p97 to a
polyubiquitin chain activates its ATPase activity and leads to ATP
hydrolysis, a critical requirement for the movement of ER substrates
into the cytoplasm [20]. To determine whether a p97-dependent
mechanism was implicated in HO-1 degradation pathway, we ﬁrst
examined the possible interaction of p97 and Ufd1 with HO-1 and/or
ubiquitinated HO-1. Both endogenous p97 and Ufd1 were co-eluted
with His-tagged-HO-1 in cells overexpressing His-tagged HO-1 and
HA-tagged ubiquitin, suggesting the recruitment of these proteins to
unmodiﬁed and/or ubiquitinated HO-1. siRNA experiments further
demonstrated that the half-life of HO-1 induced by CoPPIX was
signiﬁcantly prolonged in cells with p97 or Ufd1 knockdown. In
contrast, the turnover of induced p27, which is known to be degraded
through the ubiquitin–proteasome system [29,30], was not altered by
the knockdown of p97 or Ufd1. These data support the selectivity of
p97 and Ufd1 knockdown for HO-1 protein turnover. Although we did
not demonstrate the involvement of Npl4 in HO-1 degradation, it
is conceivable that Npl4 is also integral to this protein complex-
mediated translocation of ubiquitinated HO-1. A critical role for the
p97–Ufd1–Npl4 complex in HO-1 degradation was further supported
by the ﬁnding that Ufd1 knockdown resulted in signiﬁcant accumula-
tion of ubiquitinated HO-1.
Fig. 7. Effect of zinc on HO-1 ubiquitination. (A) HEK293 cells were treated with the indicated concentrations of TPEN for 8 h. Cell viability was then examined by a MTS-based assay.
Control cell viability was set at 100%. Data shown are the mean±SD. of three independent experiments. ⁎Pb0.01 vs control. (B) HEK293 cells transfected with His-tagged HO-1 and
HA-tagged ubiquitin plasmids were treated with the indicated concentrations of TPEN for 8 h. Cells were then lysed and His-tagged HO-1 was puriﬁed bymetal afﬁnity resin followed
by immunoblotting with antibodies against HO-1 and HA-tag. The extent of ubiquitination of HO-1 in control cells without TPEN treatment was set at 100%. Data are mean±SD.
⁎Pb0.01 vs control. (C) HEK293 cells transfected with His-tagged HO-1 and HA-tagged ubiquitin plasmids were treated with the indicated concentrations of ZnCl2 for 8 h, then His-
tagged HO-1 was isolated as described above. Data are mean±SD. ⁎Pb0.01 vs control cells. (D) HEK293 cells transfected with His-tagged HO-1 and HA-tagged ubiquitin plasmids
were treated with or without ZnCl2 (10 μM), TPEN (6 μM), or ZnCl2 plus TPEN as indicated for 8 h, then His-tagged HO-1 was isolated as described above. Data aremean±SD. ⁎Pb0.02
vs control cells; ⁎⁎Pb0.01 vs control cells; †Pb0.01 vs sTPEN-treated cells.
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ligases in substrate ubiquitination [22,26,31–37]. To test whether HO-1
breakdown was mediated by a RING-E3 whose activity is dependent
on Zn2+, we examined the effect of TPEN, a Zn2+ chelator, on HO-1
ubiquitination. We found that the non-cytotoxic concentration of TPEN
(6 μM) markedly reduced exogenous HO-1 ubiquitination. Conversely,
incubation of cellswith ZnCl2 (10 μM)enhancedHO-1ubiquitination and
blocked the inhibitory effect of TPEN. Although the speciﬁc E3 ligase
responsible for HO-1 ubiquitination has not been identiﬁed, the present
ﬁndings suggest that Zn2+-independent ligases, such as HECT or U-box-
E3, may not be involved in HO-1 degradation. Although ERAD was
initially identiﬁed as a process for the elimination of misfolded or
unassembled proteins in ER [15,16], recent studies on native ER-
membrane associated proteins demonstrated that ERAD is also involved
in the regulated degradation of speciﬁc ER proteins. For example, ERAD
mediates thedegradationof 3-hydroxy-3-methylglutaryl-CoAreductase,
an ER-anchored protein involved in cholesterol synthesis, in response to
increased sterol concentrations [38,39]. Furthermore, activation of Gprotein-coupled receptors resulting in elevation of intracellular inositol
1,4,5-triphosphate (IP3) leads to the rapid ERAD-dependent degradation
of IP3 receptor channel proteins located in the ER [40]. The present study
showed that HO-1 in the resting cells was readily degraded by the
ubiquitin–proteasome system through ERAD, suggesting that ERADmay
also have a role in maintaining the steady-state homeostasis of native
ER-associated proteins. Whether HO-1 protein turnover is regulated in
speciﬁc circumstances, such as conditions associated with various
cellular stress, remains to be determined. Identiﬁcation of the E3 ligase
responsible for HO-1 ubiquitination will be essential for the further
delineation of the detailed mechanism underlying the posttranslational
regulation of this protein after induction by stress.
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